<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Inmunoterapia &#187; guías y protocolos</title>
	<atom:link href="https://temas.sld.cu/inmunoterapia/tag/guias-y-protocolos/feed/" rel="self" type="application/rss+xml" />
	<link>https://temas.sld.cu/inmunoterapia</link>
	<description>Sitio web dedicado a la inmunoterapia en Cuba</description>
	<lastBuildDate>Wed, 24 Jan 2024 03:23:02 +0000</lastBuildDate>
	<language>es-ES</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline</title>
		<link>https://temas.sld.cu/inmunoterapia/2011/02/28/registration-trials-for-specific-immunotherapy-in-europe-advanced-guidance-from-the-new-european-medical-agency-guideline/</link>
		<comments>https://temas.sld.cu/inmunoterapia/2011/02/28/registration-trials-for-specific-immunotherapy-in-europe-advanced-guidance-from-the-new-european-medical-agency-guideline/#comments</comments>
		<pubDate>Mon, 28 Feb 2011 18:53:40 +0000</pubDate>
		<dc:creator><![CDATA[Raúl Lázaro Castro Almarales]]></dc:creator>
				<category><![CDATA[Ámbito regulatorio]]></category>
		<category><![CDATA[Europa]]></category>
		<category><![CDATA[guías y protocolos]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/inmunoterapia/?p=71</guid>
		<description><![CDATA[Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline V. Gödicke and F. Hundt. Allergy Volume 65, Issue 12, pages 1499–1505, December 2010]]></description>
		<wfw:commentRss>https://temas.sld.cu/inmunoterapia/2011/02/28/registration-trials-for-specific-immunotherapy-in-europe-advanced-guidance-from-the-new-european-medical-agency-guideline/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
